Aditxt's Target Acquisition Appili Therapeutics Announces Alignment With FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission

BusinesswireOct 31 08:30 ET

Appili Therapeutics Announces "Alignment" With FDA on ATI-1801 Development Requirements

MT NewswiresOct 31 07:57 ET

Express News | Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership With Broader Perspectives

ReutersOct 29 08:15 ET

Appili Therapeutics – Press Release Correction

GlobeNewswireOct 10 15:40 ET

Express News | Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval

ReutersOct 10 08:15 ET

Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders

GlobeNewswireSep 17 17:11 ET